These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8457449)

  • 1. Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis.
    Powles AV; Cook T; Hulme B; Baker BS; Lewis HM; Thomas E; Valdimarsson H; Fry L
    Br J Dermatol; 1993 Feb; 128(2):159-65. PubMed ID: 8457449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function after 10 years' treatment with cyclosporin for psoriasis.
    Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
    Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function after long-term low-dose cyclosporin for psoriasis.
    Powles AV; Carmichael D; Hulme B; Thomas E; McFadden J; Baker B; Valdimarsson H; Fry L
    Br J Dermatol; 1990 May; 122(5):665-9. PubMed ID: 2112945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine.
    Pei Y; Scholey JW; Katz A; Schachter R; Murphy GF; Cattran D
    Am J Kidney Dis; 1994 Apr; 23(4):528-36. PubMed ID: 8154488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal biopsy findings in long-term cyclosporin treatment of psoriasis.
    Zachariae H; Kragballe K; Hansen HE; Marcussen N; Olsen S
    Br J Dermatol; 1997 Apr; 136(4):531-5. PubMed ID: 9155953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, contraindications and side-effects.
    Zachariae H; Steen Olsen T
    Clin Nephrol; 1995 Mar; 43(3):154-8. PubMed ID: 7774070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin.
    Young EW; Ellis CN; Messana JM; Johnson KJ; Leichtman AB; Mihatsch MJ; Hamilton TA; Groisser DS; Fradin MS; Voorhees JJ
    Kidney Int; 1994 Oct; 46(4):1216-22. PubMed ID: 7861719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal structure and function effects after low dose cyclosporine in psoriasis patients: a preliminary report.
    Messana JM; Johnson KJ; Mihatsch MJ
    Clin Nephrol; 1995 Mar; 43(3):150-3. PubMed ID: 7774069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy.
    Korstanje MJ; Bilo HJ; Stoof TJ
    Br J Dermatol; 1992 Nov; 127(5):501-4. PubMed ID: 1467290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal biopsy in connection with long-term treatment of psoriasis with cyclosporine].
    Zachariae H; Kragballe K; Hansen HE; Marcussen N; Olsen S
    Ugeskr Laeger; 1998 Jul; 160(31):4534-8. PubMed ID: 9700311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.
    Lowe NJ; Wieder JM; Rosenbach A; Johnson K; Kunkel R; Bainbridge C; Bourget T; Dimov I; Simpson K; Glass E; Grabie MT
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):710-9. PubMed ID: 8912566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study.
    Assan R; Timsit J; Feutren G; Bougnères P; Czernichow P; Hannedouche T; Boitard C; Noel LH; Mihatsch MJ; Bach JF
    Clin Nephrol; 1994 Jan; 41(1):41-9. PubMed ID: 8137568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis.
    Svarstad E; Helland S; Morken T; Bostad L; Myking A; Iversen BM; Ofstad J
    Nephrol Dial Transplant; 1994; 9(10):1462-7. PubMed ID: 7816261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis: immunopathology and long-term treatment with cyclosporin.
    Fry L
    J Autoimmun; 1992 Apr; 5 Suppl A():277-83. PubMed ID: 1503622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function and blood pressure in psoriatic patients treated with cyclosporin A.
    Feutren G; Abeywickrama K; Friend D; von Graffenried B
    Br J Dermatol; 1990 Jun; 122 Suppl 36():57-69. PubMed ID: 2196085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies.
    Mihatsch MJ; Antonovych T; Bohman SO; Habib R; Helmchen U; Noel LH; Olsen S; Sibley RK; Kemény E; Feutren G
    Clin Nephrol; 1994 Jan; 41(1):23-32. PubMed ID: 8137566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():65-71. PubMed ID: 8448642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.
    Edwards BD; Chalmers RJ; O'Driscoll JB; Mitchell DM; Smith RJ; Lawson RS; Testa HJ; Ballardie FW
    Clin Nephrol; 1994 Jun; 41(6):350-6. PubMed ID: 8076438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.